Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status
Số trang: 11
Loại file: pdf
Dung lượng: 1.51 MB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Pathological stage IB-IIIA lung adenocarcinoma with an epidermal growth factor receptor (EGFR) mutation (Mt) has a high recurrence rate even after complete resection. However, there have been few reports on the risk factors for Mt recurrence. This study aimed to analyze the clinicopathological factors related to the relapsefree survival (RFS) of patients with pathological stage IB-IIIA primary lung adenocarcinoma with and without an EGFR mutation.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer EGFR mutation Pathological stage Relapse-free survival Primary lung adenocarcinoma Adjuvant chemotherapyTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 175 0 0 -
6 trang 169 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 147 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 125 0 0 -
12 trang 98 0 0
-
19 trang 76 0 0
-
17 trang 68 0 0
-
9 trang 46 0 0
-
12 trang 40 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 39 0 0